StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research note issued to investors on Saturday. The firm set a “sell” rating on the stock. Ampio Pharmaceuticals Stock Performance Ampio Pharmaceuticals Company Profile (Get Free Report) Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related […]